Clinical Trials Directory

Trials / Unknown

UnknownNCT02685449

Insulin Requirement for Pure-protein Meal in Children With Type 1 Diabetes on Insulin Pumps.

Insulin Requirement for Pure- Protein Meal in Children With Type 1 Diabetes Treated With Continuous Subcutaneous Insulin Infusion - a Cross-over, Randomized Trial.

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
70 (estimated)
Sponsor
Medical University of Warsaw · Academic / Other
Sex
All
Age
10 Years – 18 Years
Healthy volunteers
Not accepted

Summary

This is a randomized, cross-over study. The aim of this study is to compare the post-prandial glycaemic variability after pure protein meal following with an administration of square-wave bolus of meal-insulin or without any meal-insulin bolus on the other day. Prolonged post-prandial glycaemic variability will be identified using the self-monitoring of blood glucose (10-point curve) and CGMS.

Detailed description

The square-wave bolus (for meals rich in fat and/or protein) is evenly delivered over several hours as programmed by the patient. The required insulin dose will be calculated based on patient's insulin-exchange ratio. Pure protein meal will be given 3 hours after a first breakfast. To provide the minimal impact of the previous breakfast, all patients will receive up to 120 kcal of carbohydrates and \<100 kcal from protein and fat for the first breakfast (without any extended bolus) Patients receive a standardized pure protein meal at a second breakfast time. Meal insulin will be given as a square bolus or no meal -insulin will be given at all. The 5h post-meal glucose excursions will be recorded by self-blood glucose measurements (SMBG) (every 30 minutes) and continuous glucose monitoring system (CGMS). The intervention is taking part under in-patient clinical conditions.

Conditions

Interventions

TypeNameDescription
DRUGInsulin glulisineA kind of study bolus insulin will be insulin aspart if participant used insulin aspart before entering the trial
DRUGInsulin aspartA kind of study bolus insulin will be insulin lispro if participant used insulin lispro before entering the trial
DRUGInsulin lisproA kind of study bolus insulin will be insulin lispro if participant used insulin lispro before entering the trial

Timeline

Start date
2016-02-01
Primary completion
2018-02-01
Completion
2018-08-01
First posted
2016-02-18
Last updated
2016-07-29

Locations

1 site across 1 country: Poland

Source: ClinicalTrials.gov record NCT02685449. Inclusion in this directory is not an endorsement.